Development And Evaluation Of Microwave Generated Nanocomposites For Solubility Enhancement Of Orlistat Drug
DOI:
https://doi.org/10.53555/jaz.v43i1.4935Keywords:
Orlistat, Nanocomposite, Microwave Induced Diffusion Technique (MIDT), Tablet, Immediate Release etc.Abstract
The development of a technique for lowering the particle size and turning the drug into an amorphous state can increase the solubility and bioavailability of BCS Class II medications like Orlistat. A promising method for oral delivery of medications with low solubility is to create nanocomposites (NCs) utilising natural carriers. For the purpose of improving the solubility of the weakly water soluble (BCS class II) model drug Orlistat, nanocomposites were created in the current study utilising the microwave induced diffusion technique (MIDT). Due to its limited water solubility and its oral bioavailability, it is extremely low. The natural carrier’s Acacia, Xanthum gum, Gelatin powder, Chitosan, and Tragacanth were used to create the nanocomposites of orlistat. With different concentrations of medication and carriers, various physical mixture and nanocomposites formulations were created. Natural carriers were chosen based on their surfactant and wetting characteristics. According to the dissolving analysis of the optimised nanocomposites IR tablet, the dissolution rates were noticeably better in NCs IR tablet as compared to the marketed tablet. Out of four tablet formulations, tablet F2 had the shortest disintegration time, so it was chosen for further examination and an in-vitro dissolving test was carried out to see whether the tablet was releasing the medicine. The amount of medication released after 30 minutes was determined to be 91.45 ± 1.2 % as opposed to the 75.65 ± 1.3 % shown on the commercial tablet. Fourier transform infrared spectroscopy, Differential scanning calorimetry, X-ray diffraction, and Scanning electron microscopy were used to characterise the optimised nanocomposites. The nanocomposites OGAN4 (Orlistat + Acacia gum powder) formulation was shown to be optimal in terms of solubility enhancement of a drug by microwave assisted synthesis based on solubility, in-vitro drug release, and physical characterization of carriers. The MID technique used in this work remains environmentally friendly, inexpensive, then a possible technique aimed at improving solubility.
Downloads
References
Patil AA., Payghan SA., Disouza JI. Bionanocomposites: Approach in solubility and bioavailability enhancement of poorly water-soluble drugs. Int J Universe Pharm Bio Sci. 2014;3:258-68.
Khayyam S., Patwekar S., Payghan S., Disouza JI. Formulation and evaluation of sustained release tablets from solid dispersions of lovastatin. 1612 Pharmatutor; 2011. Available from: http://www.pharmatutor.org.
Amidon GL., Lennermas H., Shah VP., Crison JR. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and Figure 10: Scanning electron microscopy images of nifedipine, NIMONC and NIAMNC in vivo bioavailability. Pharm Res. 1995;3:413-20.
Varandal A., Magar D. Different approaches toward the enhancement of Drug Solubility. Journal of Advanced Pharmacy Education & Research. 2013; 3:419-425.
Godse SZ., Patil MS. Techniques for solubility enhancement of hydrophobic drugs: A Review by Journal of Advanced Pharmacy Education and Research. 2012; 325:17-22.
Shinde PR., Varandal AB. Different Approaches toward the Enhancement of Drug Solubility. World Journal of Pharmacy and Pharmaceutical Sciences. 2014; 436:625- 664.
Bergese P. Microwave generated nanocomposites for making insoluble drugs soluble. Mater Sci Eng C. 2003; 6(8):791-795.
Wang B., Zhuang X., Deng W., Cheng B. Microwave assisted synthesis of silver nanoparticles in alkali carboxymethyl chitosan solution. Engineering. 2010; 2:387-390.
Gattani S., Patwekar S. Solubility and Dissolution Enhancement of Poorly Water-soluble Ketoprofen by Microwave-assisted Bionanocomposites: In Vitro and In Vivo Study. Asian Journal of Pharmaceutics. 2016; 10(4):601-611.
Papadimitriou SA., Bikiaris D. Microwave induced enhancement of the dissolution rate of poorly water soluble Tibolone from poly (ethylene glycol) solid dispersion. J App. Poly. Sci. 2008; 108:1249-1258.
Henness S., Perry CM. Orlistat: A review of its use in the management of obesity. Drugs 2006;66:1625-56.
Mittendorfer B., Ostlund RE., Patterson BW., Klein S. Orlistat inhibits dietary cholesterol absorption. Obes Res. 2001;9:599-604.
Hill TK., Davis AL., Wheeler FB., Kelkar SS., Freund EC. Development of a self-assembled nanoparticle formulation of orlistat, Nano-ORL, with increased cytotoxicity against human tumor cell lines. Mol Pharm. 2016;13:720-8.
Sangwai M., Sardar S., Vavia P. Nano emulsified orlistat-embedded multi-unit pellet system (MUPS) with improved dissolution and pancreatic lipase inhibition. Pharm Dev Technol. 2014;19:31-41.
Dolenc A., Govedarica B., Dreu R., Kocbek P., Srcic S., Kristl J. Nanosized particles of orlistat with enhanced in vitro dissolution rate and lipase inhibition. Int J Pharm. 2010;396:149-55.
Abdelwahed W., Degobert G., Stainmesse S., Fessi H. Freeze-drying of nanoparticles: Formulation, process, and storage considerations. Adv Drug Deliv Rev. 2006;58:1688-713.
Chandrasekaran AR. Importance of in vitro-in vivo studies in pharmaceutical formulation development. Der Pharm Sin. 2011;2:218-40.
Bobe KR., Subrahmanya CR., Sarasija Suresh, Gaikwad DT., Patil MD., Khade TS. Formulation and Evaluation of Solid Dispersion of Atorvastatin with Various Carriers. International Journal of Comprehensive Pharmacy. 2011; 1(2):1-6.1.
Kishor R Rajmalle, Mohmed Zameerrudin, Jadhav SB., Kadam VS., Bharkad VB. Recent Approaches Solubility and Dissolution Enhancement Of Atorvastatin: A Review. World Journal of Pharmacy and Pharmaceutical Sciences. 2014; 3(06):534-544.
Ankush Chaudhary, Geeta Agraval, Virender kumar. Development and characterization of an Atorvastatin using skimmed milk for improved oral bioavailability. Acta Pharmaceutica Sinica B. 2012, 421-428.
Mazzo DJ. International Stability Testing. Interpharm Press Inc. USA. 2005;78: 14-25.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Snehal Wani, Atish S Mundada

This work is licensed under a Creative Commons Attribution 4.0 International License.